Home/Filings/4/0000899243-20-018261
4//SEC Filing

O'Leary James J 4

Accession 0000899243-20-018261

CIK 0001805890other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 4:05 PM ET

Size

4.5 KB

Accession

0000899243-20-018261

Insider Transaction Report

Form 4
Period: 2020-06-30
O'Leary James J
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2020-06-30$17.00/sh+300$5,100300 total

Issuer

Fusion Pharmaceuticals Inc.

CIK 0001805890

Entity typeother

Related Parties

1
  • filerCIK 0001449753

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:05 PM ET
Size
4.5 KB